ALEXA FLUOR 555 Antibody
ALEXA FLUOR 555 Antibody
Anti-LAMP3 antibody (Alexa-fluor 546) |
|||
STJ170005 | St John's Laboratory | 100 µg | 393 EUR |
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
|||
Anti-LAMP3 antibody (Alexa-fluor 647) |
|||
STJ170006 | St John's Laboratory | 100 µg | 393 EUR |
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
|||
Anti-IL3RA antibody (Alexa-fluor 488) |
|||
STJ170009 | St John's Laboratory | 100 µg | 393 EUR |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
|||
Anti-IL3RA antibody (Alexa-fluor 546) |
|||
STJ170010 | St John's Laboratory | 100 µg | 393 EUR |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
|||
Anti-IL3RA antibody (Alexa-fluor 647) |
|||
STJ170011 | St John's Laboratory | 100 µg | 393 EUR |
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
|||
Anti-CD207 antibody (Alexa-fluor 488) |
|||
STJ170014 | St John's Laboratory | 100 µg | 393 EUR |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
|||
Anti-CD207 antibody (Alexa-fluor 546) |
|||
STJ170015 | St John's Laboratory | 100 µg | 393 EUR |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
|||
Anti-CD207 antibody (Alexa-fluor 647) |
|||
STJ170016 | St John's Laboratory | 100 µg | 393 EUR |
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
|||
Anti-IL7R antibody (Alexa-fluor 488) |
|||
STJ170020 | St John's Laboratory | 100 µg | 393 EUR |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
|||
Anti-IL7R antibody (Alexa-fluor 546) |
|||
STJ170021 | St John's Laboratory | 100 µg | 393 EUR |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
|||
Anti-IL7R antibody (Alexa-fluor 647) |
|||
STJ170022 | St John's Laboratory | 100 µg | 393 EUR |
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
|||
SAM FCM (Alexa Fluor 647) |
|||
abx098902-100tests | Abbexa | 100 tests | 1233 EUR |
SAM FCM (Alexa Fluor 488) |
|||
abx098904-60tests | Abbexa | 60 tests | 1358 EUR |
Anti-RPSA Alexa Fluor® 488 |
|||
A4-829-C100 | ExBio | 0.1 mg | 310 EUR |
Anti-Hu CD16 Alexa Fluor® 488 |
|||
A4-646-T100 | ExBio | 100 tests | 269 EUR |
Goat anti Mouse IgG1 (Alexa Fluor 488) |
|||
43R-1649 | Fitzgerald | 500 ug | 570 EUR |
Description: Goat anti Mouse IgG1 secondary antibody (Alexa Fluor 488) |
|||
Alpha Fluor™ 532 acid [equivalent to Alexa Fluor™ 532 acid] |
|||
1795 | AAT Bioquest | 10 mg | 393 EUR |
Mouse IgG1-Alexa 555 conjugate (isotype control) |
|||
20102-101-A555 | Alpha Diagnostics | 50 Tests | 263 EUR |
Anti-Hu CD72 Alexa Fluor® 488 |
|||
A4-310-T100 | ExBio | 100 tests | 269 EUR |
Anti-Bov CD9 Alexa Fluor® 488 |
|||
A4-354-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD30 Alexa Fluor® 700 |
|||
A7-455-T100 | ExBio | 100 tests | 269 EUR |
Anti-Hu CD94 Alexa Fluor® 700 |
|||
A7-727-T100 | ExBio | 100 tests | 269 EUR |
Anti-Hu CD56 Alexa Fluor® 700 |
|||
A7-789-T100 | ExBio | 100 tests | 269 EUR |
AF350-streptavidin conjugate [Streptavidin, Alexa Fluor™ 350 Conjugate] |
|||
16890 | AAT Bioquest | 1 mg | 176 EUR |
AF488-streptavidin conjugate [Streptavidin, Alexa Fluor™ 488 Conjugate] |
|||
16891 | AAT Bioquest | 1 mg | 176 EUR |
AF594-streptavidin conjugate [Streptavidin, Alexa Fluor™ 594 Conjugate] |
|||
16892 | AAT Bioquest | 1 mg | 176 EUR |
AF350 Phalloidin [equivalent to Alexa Fluor® 350 phalloidin] |
|||
23150 | AAT Bioquest | 300 Tests | 306 EUR |
AF488 Phalloidin [equivalent to Alexa Fluor® 488 phalloidin] |
|||
23153 | AAT Bioquest | 300 Tests | 306 EUR |
AF594 Phalloidin [equivalent to Alexa Fluor® 594 phalloidin] |
|||
23158 | AAT Bioquest | 300 Tests | 306 EUR |
Donkey anti Goat IgG (H + L) (Alexa Fluor 594) |
|||
43R-ID005AF | Fitzgerald | 500 ug | 338 EUR |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 594) |
|||
Donkey anti Rat IgG (H + L) (Alexa Fluor 594) |
|||
43R-ID022AF | Fitzgerald | 500 ug | 364 EUR |
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594) |
|||
Donkey anti Goat IgG (H + L) (Alexa Fluor 647) |
|||
43R-ID028AF | Fitzgerald | 500 ug | 430 EUR |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 647) |
|||
Donkey anti Rat IgG (H + L) (Alexa Fluor 594) |
|||
43R-ID047AF | Fitzgerald | 500 ug | 462 EUR |
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594) |
|||
Donkey anti Chicken IgY (H + L) (Alexa Fluor 594) |
|||
43R-ID056AF | Fitzgerald | 500 ug | 343 EUR |
Description: Donkey anti Chicken IgY secondary antibody (H + L) (Alexa Fluor 594) |
|||
Donkey anti Chicken IgY (H + L) (Alexa Fluor 647) |
|||
43R-ID060AF | Fitzgerald | 300 ug | 425 EUR |
Description: Donkey anti Chicken IgY (H + L) (Fab'2) (Alexa Fluor 647) |
|||
Rabbit anti Chicken IgY (H + L) (Alexa Fluor 594) |
|||
43R-IR016AF | Fitzgerald | 1 mg | 281 EUR |
Description: Rabbit anti Chicken IgY (H + L) secondary antibody (Alexa Fluor 594) |
|||
Goat Anti-Mouse IgG(H+L) Alexa Fluor 594–conjugated |
|||
S0005 | Affbiotech | 200ul | 376 EUR |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 594–conjugated |
|||
S0006 | Affbiotech | 200ul | 376 EUR |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 647–conjugated |
|||
S0013 | Affbiotech | 200ul | 304 EUR |
Goat Anti-Mouse IgG(H+L) Alexa Fluor 647–conjugated |
|||
S0014 | Affbiotech | 200ul | 304 EUR |
Goat Anti-Mouse IgG(H+L) Alexa Fluor 488–conjugated |
|||
S0017 | Affbiotech | 200ul | 304 EUR |
Goat Anti-Rabbit IgG(H+L) Alexa Fluor 488–conjugated |
|||
S0018 | Affbiotech | 200ul | 304 EUR |
Anti-LAMP3 (human) Monoclonal Antibody (104G4) (Alexa Fluor® 488) |
|||
M09406 | BosterBio | 100ug | 565 EUR |
Description: Mouse Monoclonal LAMP3 (human) Antibody (104G4) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
|||
Anti-Hu CD3 zeta (pY153) Alexa Fluor® 488 |
|||
A4-686-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY72) Alexa Fluor® 488 |
|||
A4-712-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY142) Alexa Fluor® 488 |
|||
A4-730-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY111) Alexa Fluor® 488 |
|||
A4-737-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY153) Alexa Fluor® 647 |
|||
A6-686-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY72) Alexa Fluor® 647 |
|||
A6-712-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY142) Alexa Fluor® 647 |
|||
A6-730-C100 | ExBio | 0.1 mg | 269 EUR |
Anti-Hu CD3 zeta (pY111) Alexa Fluor® 647 |
|||
A6-737-C100 | ExBio | 0.1 mg | 269 EUR |
Donkey Anti-Goat IgG (H+L), Alexa Fluor® 594 Conjugated |
|||
Ab8011-001 | GenDepot | 1mg | 334 EUR |
Donkey Anti-Rabbit IgG (H+L), Alexa Fluor® 488 Conjugated |
|||
Ab8032-001 | GenDepot | 0.5mg | 435 EUR |
Donkey anti Goat IgG (H + L) (Fab 2) (Alexa Fluor 594) |
|||
43R-ID012AF | Fitzgerald | 300 ug | 410 EUR |
Description: Donkey anti Goat IgG (H + L) secondary antibody (Fab'2) (Alexa Fluor 594) |
|||
Anti-Langerin (human) Monoclonal Antibody (DCGM4/122D5) (Alexa Fluor® 488) |
|||
M02316 | BosterBio | 100ug | 580 EUR |
Description: Mouse Monoclonal Langerin (human) Antibody (DCGM4/122D5) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
|||
Rabbit Anti-Rat IgG (H+L)-Alexa 488 Fluor conjugate (adsorbed with human IgG) |
|||
50336 | Alpha Diagnostics | 0.5 ml | 225 EUR |
Rabbit Anti-Rat IgG (H+L)-Alexa 594 Fluor conjugate (adsorbed with human IgG) |
|||
50337 | Alpha Diagnostics | 0.5 ml | 225 EUR |
AG 555 |
|||
HY-15336 | MedChemExpress | 10mM/1mL | 126 EUR |
AG 555 |
|||
B6377-10 | ApexBio | 10 mg | 144 EUR |
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation. |
|||
AG 555 |
|||
B6377-25 | ApexBio | 25 mg | 276 EUR |
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation. |
|||
AG 555 |
|||
B6377-50 | ApexBio | 50 mg | 447 EUR |
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation. |
|||
MCC-555 |
|||
C4892-1 | ApexBio | 1 mg | 158 EUR |
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism. |
|||
MCC-555 |
|||
C4892-10 | ApexBio | 10 mg | 918 EUR |
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism. |
|||
MCC-555 |
|||
C4892-5 | ApexBio | 5 mg | 538 EUR |
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism. |
|||
Alpha Fluor™ 488 amine |
|||
1705 | AAT Bioquest | 1 mg | 306 EUR |
Alpha Fluor™ 488 Hydroxylamine |
|||
1900 | AAT Bioquest | 1 mg | 306 EUR |
Tide Fluor 2-LL-37 |
|||
H-8286.0100 | Bachem | 0.1mg | 312 EUR |
Description: Sum Formula: C205H340N60O53+dye |
|||
Tide Fluor 2-LL-37 |
|||
H-8286.0500 | Bachem | 0.5mg | 1017 EUR |
Description: Sum Formula: C205H340N60O53+dye |
|||
Recombinant (E.Coli, His-tag) HIV-1 pol Integrase |
|||
RP-555 | Alpha Diagnostics | 10 ug | 164 EUR |
IL12 B Recombinant Protein |
|||
96-555 | ProSci | 0.02 mg | 390.5 EUR |
Description: Interleukin-12 (IL12) is also known as natural killer cell stimulatory factor (NKSF), cytotoxic lymphocyte maturation factor (CLMF) , is a heterodimeric cytokine encoded by two separate genes, IL-12A (p35) and IL-12B (p40). IL12 is naturally produced by dendritic cells, macrophages and human B-lymphoblastoid cells (NC-37) in response to antigenic stimulation. IL-12 is involved in the differentiation of naive T cells into Th0 cells and plays an important role in the activities of natural killer cells and T lymphocytes.IL-12 also has anti-angiogenic activity, which means it can block the formation of new blood vessels.Interleukin-12 subunit beta (IL12B) also known as NKSF2, CLMF2 and P40. Interleukin-12 subunit beta has been shown to interact with IL23. A large excess of monomeric IL12B is also secreted by the cells producing IL12, and exhibits no demonstrable biological activity. Overexpression of IL12B gene has been shown to be associated with the pathogenesis of multiple sclerosis. In addition, studies have revealed that the promoter polymorphism of this gene is implicated in the severity of atopic and non-atopic asthma in children. |